Wilks Brothers’s Eli Lilly LLY Stock Holding History

Wilks Brothers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,300	Closed	-$1.22M	–	67
2018 Q2	$1.22M	Buy	+14,300	New	+$1.17M	0.13%	61

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wilks Brothers's LLY Position: Q3 2018 in Review

Wilks Brothers sold out of Eli Lilly (LLY) in Q3 2018, closing a stake of 14,300 shares — an estimated $1.22M sold.

Wilks Brothers first reported a position in LLY in Q2 2018 and held it in 1 quarter. The position peaked at $1.22M in Q2 2018. 1,432 funds tracked by Wall St. Rank hold LLY as of Q3 2018.

Wilks Brothers reported no remaining Eli Lilly position as of Q3 2018 after selling out during the quarter.
Wilks Brothers sold 14,300 Eli Lilly shares in Q3 2018, an estimated $1.22M.
Wilks Brothers first reported a position in Eli Lilly in Q2 2018 and held it in 1 quarter.
Wilks Brothers's Eli Lilly position peaked at $1.22M in Q2 2018.
1,432 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2018.

Based on Wilks Brothers's 13F filing for Q3 2018, filed 9 Nov 2018.